SHANGHAI, March 13, 2025 /PRNewswire/ -- WuXi XDC Cayman Inc. ("WuXi XDC", or the "Company", stock code: 2268.HK), a leading global CRDMO (Contract Research, Development, and Manufacturing Organization) specializing in antibody-drug conjugates (ADCs) and other bioconjugates, has been...
Read More Details
Finally We wish PressBee provided you with enough information of ( WuXi XDC Wins Multiple Awards at Asia-Pacific Biopharma Excellence Awards 2025 )
Also on site :
- Real reason why Rite Aid hopes shoppers won’t transfer prescriptions after second bankruptcy and 68 closures
- Family Searches for Missing Teen Last Seen in Port Hueneme
- US judge dismisses case against migrants caught in new military zone